AV Troitsky¹*, TN Bystrova¹, RA Knyazev¹, NV Trifonova¹, AA Rozhkov², NA Mamontov², KA Rozhkova² and BA Zhigadlo²

¹Federal Research Centre for Fundamental and Translational Medicine, Novosibirsk, Russia
²Innovative Health Technologies LLC, Novosibirsk, Russia

*Corresponding Author: AV Troitsky, Federal Research Centre for Fundamental and Translational Medicine, Novosibirsk, Russia.

Received: June 24, 2024; Published: July 31, 2024

Abstract

The effects of low-molecular chitosan were studied in experimental models of leukopenia in mice caused by cyclophosphamide and gamma radiation. The oncoprotective effect of low-molecular chitosan on the solid lymphosarcoma model of mice was studied. Low-molecular chitosan has been shown to have an oncoprotective effect and to effectively compensate for leukopenia caused by cytostatic and gamma radiation.

 Keywords: Chitosan; Cytostatic and Radiation Leukopenia; Cancer Protection

References

1. Vermorken Jan B. “Cetuximab: Its unique place in head and neck cancer treatment”. Biologics Targets and Therapy 1 (2013): 77-90.
2. Zhang J., et al. “Erlotinib for advanced hepatocellular carcinoma. A systematic review of phase II/III clinical trials”. Saudi Medical Journal11 (2016): 1184-1190.
3. Greenhalgh J., et al. “Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation”. Health Technology Assessment47 (2015): 1-134.
4. Bouabdallah K., et al. “Temsirolimus in the treatment of mantle cell lymphoma: frequency and management of adverse effects”. Current Opinion Oncology 25 (2013): S1-12.
5. Ambrosio AJ., et al. “Vintafolide (EC145) for the treatment of folate-receptor-alpha positive platinum-resistant ovarian cancer”. Expert Review of Clinical Pharmacology 4 (2014): 443-450.
6. Zhang Y., et al. “Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China”. Cancer Research Clinical Oncology11 (2018): 2177-2186.
7. Motta F., et al. “Mushrooms and immunity”. Autoimmune 117 (2021): 102576.
8. Taek Joon Yoon., et al. “The effects of β-glucans on cancer metastasis”. Anti-Cancer Agents in Medicinal Chemistry 5 (2013): 699-708.
9. Sabrin H Albeituni and Jun Yan. “The effects of β-glucans on dendritic cells and implications for cancer therapy”. Anti-Cancer Agents in Medicinal Chemistry 5 (2013): 689-698.
10. Gorshenin DS., et al. “The use of chitosan and its derivatives in immunotherapy of malignant neoplasms”. Immunology5 (2020): 470-478.

Citation

Citation: AV Troitsky., et al. “Experimental Assessment of the Oncoprotective Properties of Low-Molecular Chitosan and its Effects on Cytostatic and Radiation Myelosuppression”.Acta Scientific Medical Sciences 8.8 (2024): 177-181.

Copyright

Copyright: © 2024 AV Troitsky., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.